125 related articles for article (PubMed ID: 34783377)
21. Preoperative prognostic factors for biochemical recurrence after robot-assisted radical prostatectomy in Japan.
Hashimoto T; Yoshioka K; Gondo T; Ozu C; Horiguchi Y; Namiki K; Ohno Y; Ohori M; Nakashima J; Tachibana M
Int J Clin Oncol; 2014 Aug; 19(4):702-7. PubMed ID: 24048883
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.
Tanimoto R; Fashola Y; Scotland KB; Calvaresi AE; Gomella LG; Trabulsi EJ; Lallas CD
BMC Urol; 2015 Apr; 15():27. PubMed ID: 25879548
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer biochemical recurrence rates after robotic-assisted laparoscopic radical prostatectomy.
Ginzburg S; Nevers T; Staff I; Tortora J; Champagne A; Kesler SS; Laudone VP; Wagner JR
JSLS; 2012; 16(3):443-50. PubMed ID: 23318071
[TBL] [Abstract][Full Text] [Related]
24. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
25. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
[TBL] [Abstract][Full Text] [Related]
26. Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort.
Zanaty M; Alnazari M; Ajib K; Lawson K; Azizi M; Rajih E; Alenizi A; Hueber PA; Tolmier C; Meskawi M; Saad F; Pompe RS; Karakiewicz PI; El-Hakim A; Zorn KC
World J Urol; 2018 Jan; 36(1):1-6. PubMed ID: 29052761
[TBL] [Abstract][Full Text] [Related]
27. Ultrasensitive prostate-specific antigen level as a predictor of biochemical progression after robot-assisted radical prostatectomy: Towards risk adapted follow-up.
Grivas N; de Bruin D; Barwari K; van Muilekom E; Tillier C; van Leeuwen PJ; Wit E; Kroese W; van der Poel H
J Clin Lab Anal; 2019 Feb; 33(2):e22693. PubMed ID: 30365194
[TBL] [Abstract][Full Text] [Related]
28. A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.
Athanasiou A; Tennstedt P; Wittig A; Huber R; Straub O; Schiess R; Steuber T
PLoS One; 2021; 16(11):e0259093. PubMed ID: 34767586
[TBL] [Abstract][Full Text] [Related]
29. Optimising preoperative risk stratification tools for prostate cancer using mpMRI.
Reisæter LAR; Fütterer JJ; Losnegård A; Nygård Y; Monssen J; Gravdal K; Halvorsen OJ; Akslen LA; Biermann M; Haukaas S; Rørvik J; Beisland C
Eur Radiol; 2018 Mar; 28(3):1016-1026. PubMed ID: 28986636
[TBL] [Abstract][Full Text] [Related]
30. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
31. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
[TBL] [Abstract][Full Text] [Related]
32. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study.
Alemozaffar M; Sanda M; Yecies D; Mucci LA; Stampfer MJ; Kenfield SA
Eur Urol; 2015 Mar; 67(3):432-8. PubMed ID: 24582327
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.
Hu JC; Gandaglia G; Karakiewicz PI; Nguyen PL; Trinh QD; Shih YC; Abdollah F; Chamie K; Wright JL; Ganz PA; Sun M
Eur Urol; 2014 Oct; 66(4):666-72. PubMed ID: 24602934
[TBL] [Abstract][Full Text] [Related]
34. Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
Fossati N; Karnes RJ; Cozzarini C; Fiorino C; Gandaglia G; Joniau S; Boorjian SA; Goldner G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T; Briganti A
Eur Urol; 2016 Apr; 69(4):728-733. PubMed ID: 26497924
[TBL] [Abstract][Full Text] [Related]
35. Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial.
Sooriakumaran P; Pini G; Nyberg T; Derogar M; Carlsson S; Stranne J; Bjartell A; Hugosson J; Steineck G; Wiklund PN
Eur Urol; 2018 Apr; 73(4):618-627. PubMed ID: 28882327
[TBL] [Abstract][Full Text] [Related]
36. A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons.
Silberstein JL; Su D; Glickman L; Kent M; Keren-Paz G; Vickers AJ; Coleman JA; Eastham JA; Scardino PT; Laudone VP
BJU Int; 2013 Feb; 111(2):206-12. PubMed ID: 23356747
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
O'Brien MF; Cronin AM; Fearn PA; Smith B; Stasi J; Guillonneau B; Scardino PT; Eastham JA; Vickers AJ; Lilja H
J Clin Oncol; 2009 Aug; 27(22):3591-7. PubMed ID: 19506163
[TBL] [Abstract][Full Text] [Related]
38. Predictive postoperative model for biochemical recurrence in patients with localized prostate cancer treated with radical prostatectomy as monotherapy.
Molina Escudero R; Herranz-Amo F; Paez-Borda A; Hernandez Fernandez C
Arch Esp Urol; 2014 Apr; 67(3):259-67. PubMed ID: 24840591
[TBL] [Abstract][Full Text] [Related]
39. Impact of Variations in Prostatic Apex Shape on Apical Margin Positive Rate After Radical Prostatectomy: Robot-Assisted Laparoscopic Radical Prostatectomy vs Open Radical Prostatectomy.
Yu YD; Lee M; Hong SK; Byun SS; Lee SE; Lee S
J Endourol; 2018 Jan; 32(1):46-53. PubMed ID: 29212368
[TBL] [Abstract][Full Text] [Related]
40. Assessments of Neoadjuvant Hormone Therapy Followed by Robotic-Assisted Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer.
Hu JC; Hung SC; Ou YC
Anticancer Res; 2017 Jun; 37(6):3143-3150. PubMed ID: 28551656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
